@FierceBiotech: Gates Foundation adds $50M to help speed Ebola drug development efforts. Story | Follow @FierceBiotech
@JohnCFierce: Analysts: Pfizer execs say they're locked-and-loaded on tax inversion, and open to targets - via @TracyStaton. Article | Follow @JohnCFierce
@DamianFierce: Biotech's sprawling PED scandal widens as @adamfeuerstein admits that he "juices" daily. Report | Follow @DamianFierce
@EmilyMFierce: Uh oh. Survival rate of Ebola may be less than what we think. More from Science | Follow @EmilyMFierce
> Germany's Evotec AG has extended its collaboration with the CHDI Foundation, gaining funding for 52 scientists working on Huntington's disease. Release
> San Carlos, CA-based Cellerant Therapeutics has been awarded $47.5 million under a second option exercised by the Biomedical Advanced Research and Development Authority. The money will be earmarked for CLT-008, a cell-based therapy for hematopoietic sub-syndrome of Acute Radiation Syndrome. Release
> Montreal-based Mimetogen Pharmaceuticals says it garnered positive top line data from its second clinical study with MIM-D3, its lead drug for the treatment of dry eye syndrome. Release
Medical Device News
@FierceMedDev: Med tech M&A beware: Top Senate Democrats reveal plan to crack down on inversions. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI: ACLA head makes case against FDA LDT regulation to Congress. Story | Follow @VarunSaxena2
@MichaelGFierce: ICYMI: UO, Berkeley team tailors ultrathin peptoid nanosheets for delivery using oil and water. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: Top Senate Democrats unveil plans to curb corporate tax inversions. Reuters story | Follow @EmilyWFierce
> Harvard gets DARPA grant to develop soft, mobility exosuit. More
> Blackberry to integrate medical devices in India. Article
> Med tech M&A beware: Top Senate Democrats reveal plan to crack down on inversions. Story
Pharma News
@FiercePharma: Immunotherapy vaccine combo cuts recurrence in HER2 breast cancer patients. News | Follow @FiercePharma
@EricPFierce: Merck & Co is again shipping BCG vaccine but Sanofi is not. Story | Follow @EricPFierce
@CarlyHFierce: FDA approves Sanofi's Menactra as meningococcal booster. More | Follow @CarlyHFierce
> Takeda preps to launch Orexigen's obesity drug Contrave as Novo's Saxenda looms. Story
> Meet Baxalta, the pharma spinoff Baxter plans to unleash in 2015. Article
> The huge price hike as sales strategy, taken to extremes by Retrophin. News
Vaccines News
> Glaxo's Ebola vaccine passes key animal test as human trials begin. News
> Immunotherapy vaccine combo cuts recurrence in HER2 breast cancer patients. More
> New problems at GSK flu vaccine plant will impact U.S., Canada orders. Story
> Takeda on track for dengue vaccine nods in 2017-18. Article
> FDA approves Sanofi's Menactra as meningococcal booster. Item
Pharma Manufacturing News
> Apotex recalls Paxil tainted at GSK plant. Story
> Sources: FDA inspectors in Sun plant that has had recalls. More
> FDA fight with compounder tests its patience and its limits. Article
> Hospira will prep Indian workers at Vizag 'university.' Story
> Merck again shipping BCG cancer treatment but Sanofi still is not. Report